890MO Phase I Alexander study of AUTO3, the first CD19/22 dual targeting CAR.T cell, with pembrolizumab in patients with relapsed/refractory (r/r) DLBCL
Autor: | C. Bachier, Eleni Tholouli, Y. Zhang, Martin Pule, David Irvine, Robert T. Chen, N. Bartlet, K. Ardesha, Wendy Osborne, Muhammad Al-Hajj, Maria A V Marzolini, Nushmia Z. Khokhar, Vijay G R Peddareddigari, Simon Thomas, Aravind Ramakrishnan, Maud Jonnaert, P. McSweeney |
---|---|
Rok vydání: | 2020 |
Předmět: | |
Zdroj: | Annals of Oncology. 31:S651 |
ISSN: | 0923-7534 |
Databáze: | OpenAIRE |
Externí odkaz: |